8-K
Current Report
Design Therapeutics, Inc. Filed Acc 0000950170-24-074243
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading dsgn-20240613.htm…